Abstract
We performed a retrospective analysis of 88 adult patients with B-ALL diagnosed in our center by a flow-cytometric assessment. Immunophenotypic expression of leukemic cells was explored by simultaneous evaluation of positivity, percentage of expressing cells and median fluorescence intensity (MFI). BCR/ABL1 fusion transcripts were assessed by RT-PCR analysis and were identified in 36 patients (40.9%). CD10 and CD34 were positive in the totality of BCR/ABL1-positive cases. Patients with gene rearrangement had a greater frequency of CD66c, CD13 and CD33 positivity compared with BCR/ABL1-negative cases. Moreover, BCR/ABL1-positive cases exhibited a greater median percentage and MFI values of CD13, CD33, CD66c, CD10, CD34 and CD25 expressions, but a lower median percentage and MFI values of CD38 and CD22 expressions than patients without gene rearrangement. Multivariate logistic regression analysis showed that CD10, CD38 and CD13 expressions were independent predictors for the presence of BCR/ABL1 rearrangement. Predictive probabilities of molecular occurrence based on these markers are proposed. © 2017 International Clinical Cytometry Society.
Lingua originale | English |
---|---|
pagine (da-a) | 468-476 |
Numero di pagine | 9 |
Rivista | Cytometry Part B - Clinical Cytometry |
Volume | 94 |
DOI | |
Stato di pubblicazione | Pubblicato - 2018 |
Keywords
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- B cell acute lymphoblastic leukemia
- B-Lymphocytes
- BCR/ABL1
- Biomarkers, Tumor
- Female
- Flow Cytometry
- Fusion Proteins, bcr-abl
- Gene Rearrangement
- Humans
- Immunophenotyping
- Leukemia, B-Cell
- Male
- Middle Aged
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Retrospective Studies
- Young Adult
- immunophenotype